Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: First evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control

Parasites and Vectors

Volumn 5, Issue 1, 2012, Pages

  Tekle, Afework Hailemariam ^a   Elhassan, Elizabeth ^b   Isiyaku, Sunday ^b   Amazigo, Uche V ^c   Bush, Simon ^b   Noma, Mounkaila ^a   Cousens, Simon ^d   Abiose, Adenike ^e   Remme, Jan H ^f  

^a World Health Organization Ouagadougou   (Burkina Faso)

^b SIGHTSAVERS   (United Kingdom)

^c Sightsavers Nigeria Country Office ^*  (Nigeria)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e Sightcare International   (Nigeria)

^f APOC   (France)

Author keywords

APOC; elimination; epidemiological evaluation; Kaduna Nigeria; Onchocerciasis

Indexed keywords

IVERMECTIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; ERADICATION THERAPY; FEASIBILITY STUDY; FEMALE; HUMAN; INFANT; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MICROFILARIA; NIGERIA; NONHUMAN; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD;

ADOLESCENT; ADULT; ANIMALS; ANTIPARASITIC AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE ERADICATION; FEMALE; HUMANS; INFANT; IVERMECTIN; MALE; MIDDLE AGED; NIGERIA; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; PREVALENCE; PUBLIC HEALTH; YOUNG ADULT;

EID: 84856564960     PISSN: None     EISSN: 17563305     Source Type: Journal    
DOI: 10.1186/1756-3305-5-2822313631     Document Type: Article

References (29)

1. World Health Organization: Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. World Health Organ Tech Rep Ser 1995, 852:1-104.
2. Remme JHF, Feenstra P, Lever PR, Medici AC, Morel CM, Noma M, Ramaiah KD, Richards F, Seketeli A, Schmunis G, Gabriel Schmunis, van Brakel WH, Anna Vassall: Tropical diseases targeted for elimination: Chagas disease, lymphatic filariasis, onchocerciasis and leprosy. In Disease Control Priorities in Developing Countries. second edition. Edited by: Jamison DT, Breman JG, Measham AR. New York: Oxford University Press; 2006:433-449.
3. Colatrella B: The Mectizan Donation Program: 20 years of successful collaboration - a retrospective. Ann Trop Med Parasitol 2008, 102(Suppl 1):7-11.
4. Amazigo U: The African Programme for Onchocerciasis Control (APOC). Ann Trop Med Parasitol 2008, 102(Suppl 1):19-22.
5. Basanez MG, Pion SD, Boakes E, Filipe JA, Churcher TS, Boussinesq M: Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. Lancet Infect Dis 2008, 8:310-322. (Pubitemid 351615758)
6. Abiose A, Jones BR, Cousens SN, Murdoch I, Cassels-Brown A, Babalola OE, Alexander ND, Nuhu I, Evans J, Ibrahim Mohammed AO: Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet 1993, 341:130-134. (Pubitemid 23029304)
7. De Sole G, Remme J, Awadzi K, Accorsi S, Alley ES, Ba O, Dadzie KY, Giese J, Karam M, Keita FM: Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull World Health Organ 1989, 67:707-719. (Pubitemid 20090342)
8. Remme JH: Research for control: the onchocerciasis experience. Trop Med Int Health 2004, 9:243-254.
9. Ndyomugyenyi R, Tukesiga E, Buttner DW, Garms R: The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda. Trop Med Int Health 2004, 9:882-886. (Pubitemid 39120146)
10. Winnen M, Plaisier AP, Alley ES, Nagelkerke NJ, van Oortmarssen G, Boatin BA, Habbema JD: Can ivermectin mass treatments eliminate onchocerciasis in Africa? Bull World Health Organ 2002, 80:384-391.
11. Duke BO: Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms. Parasitology 2005, 130:447-453.
12. Cupp EW, Duke BO, Mackenzie CD, Guzman JR, Vieira JC, Mendez-Galvan J, Castro J, Richards F, Sauerbrey M, Dominguez A, Eversole R, CUPP MS: The effects of long-term community level treatment with ivermectin (Mectizan) on adult Onchocerca volvulus in Latin America. Am J Trop Med Hyg 2004, 71:602-607. (Pubitemid 39601159)
13. APOC: Year 2010 Progress Report; 1st September 2009 - 31st August 2010. Ouagadougou: African Programme for Onchocerciasis Control, World Health Organisation; 2010.
14. Thylefors B, Alleman M: Towards the elimination of onchocerciasis. Ann Trop Med Parasitol 2006, 100:733-746. (Pubitemid 46940910)
15. Dadzie Y, Neira M, Hopkins D: Final report of the conference on the eradicability of onchocerciasis. Filaria J 2003, 2:2.
16. Diawara L, Traore MO, Badji A, Bissan Y, Doumbia K, Goita SF, Konate L, Mounkoro K, Sarr MD, Seck AF, Laurent Toe, Seyni Toure, Remme HFJan: Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in mali and senegal. PLoS Negl Trop Dis 2009, 3:e497.
17. Abiose A, Murdoch I, Babalola O, Cousens S, Liman I, Onyema J, Evans J, Gregory W, Jones B: Distribution and aetiology of blindness and visual impairment in mesoendemic onchocercal communities, Kaduna State, Nigeria. Kaduna Collaboration for Research on Onchocerciasis. Br J Ophthalmol 1994, 78:8-13. (Pubitemid 24035235)
18. APOC: Conceptual and operational framework of onchocerciasis elimination with ivermectin treatment Ouagadougou: African Programme for Onchocerciasis Control; 2010.
19. Prost A, Prod'hon J: [Parasitological diagnosis of onchocerciasis. A critical review of present methods (author's transl)]. Med Trop Mars 1978, 38:519-532.
20. World Health Organization: WHO Expert Committee on Onchocerciasis. Third report. World Health Organ Tech Rep Ser 1987, 752:1-167.
21. Remme J, Ba O, Dadzie KY, Karam M: A force-of-infection model for onchocerciasis and its applications in the epidemiological evaluation of the Onchocerciasis Control Programme in the Volta River basin area. Bull World Health Organ 1986, 64:667-681. (Pubitemid 17208606)
22. Cousens S, Cassels-Brown A, Murdoch I, Babalola O, Jatau D, Alexander N, Evans J, Danboyi P, Abiose A, Jones B: Impact of annual dosing with ivermectin on progression of onchocercal visual field loss. Bull World Health Organ 1997, 75:229-236. (Pubitemid 27373562)
23. Brieger WR, Okeibunor JC, Abiose AO, Wanji S, Elhassan E, Ndyomugyenyi R, Amazigo UV: Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria. Parasit Vectors 2011, 4:152.
24. Agoua H, Alley ES, Hougard JM, Akpoboua KL, Boatin B, Seketeli A: Etudes entomologiques de post-traitement dans le Programme de Lutte contre l'Onchocercose en Afrique de l'Ouest. Parasite 1995, 2:281-288.
25. Hougard JM, Alley ES, Yameogo L, Dadzie KY, Boatin BA: Eliminating onchocerciasis after 14 years of vector control: a proved strategy. J Infect Dis 2001, 184:497-503. (Pubitemid 32718514)
26. Gustavsen K, Hopkins A, Sauerbrey M: Onchocerciasis in the Americas: from arrival to (near) elimination. Parasit Vectors 2011, 4:205.
27. Plaisier AP, van Oortmarssen GJ, Remme J, Habbema JD: The reproductive lifespan of Onchocerca volvulus in West African savanna. Acta Trop 1991, 48:271-284.
28. Duerr HP, Raddatz G, Eichner M: Control of onchocerciasis in Africa: threshold shifts, breakpoints and rules for elimination. Int J Parasitol 2011, 41:581-589.
29. Dadzie KY, Remme J, De Sole G, Boatin B, Alley ES, Ba O, Samba EM: Onchocerciasis control by large-scale ivermectin treatment. Lancet 1991, 337:1358-1359.